Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qizhen Shi

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Journal of Thrombosis and Haemostasis : JTH|August 10, 2024
Evaluating clinically translatable conditioning for platelet gene therapy in murine hemophilia A with inhibitorsYingyu Chen, Jing Li, Jocelyn A Schroeder, et al.
International Immunopharmacology|July 27, 2024
Anti-mCD20 in combination with α-mCXCL13 monoclonal antibody inhibits anti-FVIII antibody development in hemophilia A miceQiaoyun Zheng, Kehan Lin, Na Zhang, et al.
Journal of Thrombosis and Haemostasis : JTH|January 5, 2019
The impact of GPIbα on platelet-targeted FVIII gene therapy in hemophilia A mice with pre-existing anti-FVIII immunityJuan Chen, Jocelyn A Schroeder, Xiaofeng Luo, et al.
Journal of Molecular Graphics & Modelling|September 26, 2006
Pyrolysis mechanism of carbon matrix precursor cyclohexane--the formation of condensed-ring aromatics and the growing process of moleculesHui Wang, Haifeng Yang, Wang Chuang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 18, 2013
Platelet gene therapy by lentiviral gene delivery to hematopoietic stem cells restores hemostasis and induces humoral immune tolerance in FIX(null) miceYingyu Chen, Jocelyn A Schroeder, Erin L Kuether, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Pre-existing anti-factor VIII immunity alters therapeutic platelet-targeted factor VIII engraftment following busulfan conditioning through cytotoxic CD8 T cellsWeiqing Jing, Christina K Baumgartner, Feng Xue, et al.
Blood Advances|January 13, 2026
Impact of antiplatelet therapy on the hemostatic efficacy of platelet-targeted FVIII gene therapy in hemophilia A miceHongyin Yu, Jocelyn A Schroeder, Jeremy G Mattson, et al.
Blood|April 8, 2014
A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIIIScot A Fahs, Matthew T Hille, Qizhen Shi, et al.
Journal of Cellular Physiology|June 9, 2020
In vivo enrichment of genetically manipulated platelets for murine hemophilia B gene therapyYingyu Chen, Jocelyn A Schroeder, Chunyan Gao, et al.
Molecular Therapy. Nucleic Acids|February 12, 2021
Platelet gene therapy induces robust immune tolerance even in a primed model via peripheral clonal deletion of antigen-specific T cellsJing Li, Juan Chen, Jocelyn A Schroeder, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Journal of Thrombosis and Haemostasis : JTH|August 10, 2024
Evaluating clinically translatable conditioning for platelet gene therapy in murine hemophilia A with inhibitorsYingyu Chen, Jing Li, Jocelyn A Schroeder, et al.
International Immunopharmacology|July 27, 2024
Anti-mCD20 in combination with α-mCXCL13 monoclonal antibody inhibits anti-FVIII antibody development in hemophilia A miceQiaoyun Zheng, Kehan Lin, Na Zhang, et al.
Journal of Thrombosis and Haemostasis : JTH|January 5, 2019
The impact of GPIbα on platelet-targeted FVIII gene therapy in hemophilia A mice with pre-existing anti-FVIII immunityJuan Chen, Jocelyn A Schroeder, Xiaofeng Luo, et al.
Journal of Molecular Graphics & Modelling|September 26, 2006
Pyrolysis mechanism of carbon matrix precursor cyclohexane--the formation of condensed-ring aromatics and the growing process of moleculesHui Wang, Haifeng Yang, Wang Chuang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 18, 2013
Platelet gene therapy by lentiviral gene delivery to hematopoietic stem cells restores hemostasis and induces humoral immune tolerance in FIX(null) miceYingyu Chen, Jocelyn A Schroeder, Erin L Kuether, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Pre-existing anti-factor VIII immunity alters therapeutic platelet-targeted factor VIII engraftment following busulfan conditioning through cytotoxic CD8 T cellsWeiqing Jing, Christina K Baumgartner, Feng Xue, et al.
Blood Advances|January 13, 2026
Impact of antiplatelet therapy on the hemostatic efficacy of platelet-targeted FVIII gene therapy in hemophilia A miceHongyin Yu, Jocelyn A Schroeder, Jeremy G Mattson, et al.
Blood|April 8, 2014
A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIIIScot A Fahs, Matthew T Hille, Qizhen Shi, et al.
Journal of Cellular Physiology|June 9, 2020
In vivo enrichment of genetically manipulated platelets for murine hemophilia B gene therapyYingyu Chen, Jocelyn A Schroeder, Chunyan Gao, et al.
Molecular Therapy. Nucleic Acids|February 12, 2021
Platelet gene therapy induces robust immune tolerance even in a primed model via peripheral clonal deletion of antigen-specific T cellsJing Li, Juan Chen, Jocelyn A Schroeder, et al.
Pageof 6